Simplifying Protease Inhibitor Therapy with Once-Daily Dosing of Saquinavir Soft-Gelatin Capsules/Ritonavir (1600/100 mg): HIVNAT 001.3 Study - Concepedia

Concepedia

Publication | Closed Access

Simplifying Protease Inhibitor Therapy with Once-Daily Dosing of Saquinavir Soft-Gelatin Capsules/Ritonavir (1600/100 mg): HIVNAT 001.3 Study

55

Citations

8

References

2002

Year

Peter Cardiello, Rolf P. van Heeswijk, Elly A. Hassink, Preeyaporn Srasuebkul, Apicha Mahanontharit, Tarika M. Samor, Wassana Worarien, Jos H. Beijnen, Richard M. W. Hoetelmans, Kiat Ruxrungtham,

JAIDS Journal of Acquired Immune Deficiency Syndromes

Abstract

Clinical and pharmacokinetic data support once-daily SQV-SGC/RTV (1600/100 mg) with two NRTIs as a convenient and safe therapeutic regimen to maintain viral suppression and immune function in HIV-1-infected patients with plasma viral loads of <50 copies/mL.

References

	Year	Citations

Page 1